Redmile Group as of Sept. 30, 2017
Portfolio Holdings for Redmile Group
Redmile Group holds 65 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Array BioPharma | 10.7 | $216M | 18M | 12.30 | |
| Amicus Therapeutics (FOLD) | 8.2 | $166M | 11M | 15.08 | |
| Puma Biotechnology (PBYI) | 5.4 | $109M | 907k | 119.75 | |
| Seattle Genetics | 5.0 | $100M | 1.8M | 54.41 | |
| Clovis Oncology | 4.0 | $82M | 997k | 82.40 | |
| Alder Biopharmaceuticals | 3.9 | $79M | 6.5M | 12.25 | |
| AstraZeneca (AZN) | 3.8 | $76M | 2.2M | 33.88 | |
| Insmed (INSM) | 3.1 | $62M | 2.0M | 31.21 | |
| ImmunoGen | 3.0 | $62M | 8.1M | 7.65 | |
| Regenxbio Inc equity us cm (RGNX) | 2.7 | $55M | 1.7M | 32.95 | |
| Penumbra (PEN) | 2.5 | $51M | 566k | 90.30 | |
| Wave Life Sciences (WVE) | 2.4 | $49M | 2.3M | 21.75 | |
| Atara Biotherapeutics (ATRA) | 2.4 | $48M | 2.9M | 16.55 | |
| Livanova Plc Ord (LIVN) | 2.2 | $44M | 633k | 70.06 | |
| Centene Corporation (CNC) | 1.9 | $39M | 405k | 96.77 | |
| ICU Medical, Incorporated (ICUI) | 1.9 | $38M | 202k | 185.85 | |
| Aetna | 1.8 | $37M | 234k | 159.01 | |
| Audentes Therapeutics | 1.8 | $36M | 1.3M | 28.01 | |
| Oxford Immunotec Global | 1.7 | $35M | 2.1M | 16.80 | |
| Array Biopharma Inc note 3.000% 6/0 | 1.7 | $34M | 19M | 1.80 | |
| Gw Pharmaceuticals Plc ads | 1.7 | $34M | 339k | 101.49 | |
| eHealth (EHTH) | 1.6 | $32M | 1.3M | 23.89 | |
| Molina Healthcare (MOH) | 1.6 | $32M | 461k | 68.76 | |
| Pra Health Sciences | 1.5 | $31M | 402k | 76.17 | |
| Endologix | 1.4 | $29M | 6.5M | 4.46 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.4 | $29M | 189k | 152.04 | |
| Nightstar Therapeutics | 1.4 | $29M | 1.8M | 16.30 | |
| Irhythm Technologies (IRTC) | 1.4 | $29M | 552k | 51.88 | |
| Xencor (XNCR) | 1.4 | $28M | 1.2M | 22.92 | |
| La Jolla Pharmaceuticl Com Par | 1.2 | $25M | 723k | 34.78 | |
| Epizyme | 1.1 | $23M | 1.2M | 19.05 | |
| Chimerix (CMRX) | 1.1 | $22M | 4.2M | 5.25 | |
| Diplomat Pharmacy | 1.0 | $20M | 957k | 20.71 | |
| Invitae (NVTAQ) | 1.0 | $20M | 2.1M | 9.37 | |
| Boston Scientific Corporation (BSX) | 0.9 | $18M | 604k | 29.17 | |
| Glycomimetics (GLYC) | 0.8 | $17M | 1.2M | 13.99 | |
| Medpace Hldgs (MEDP) | 0.8 | $16M | 500k | 31.90 | |
| Amedisys (AMED) | 0.8 | $16M | 284k | 55.96 | |
| Jounce Therapeutics | 0.7 | $15M | 956k | 15.58 | |
| Inc Resh Hldgs Inc cl a | 0.7 | $14M | 268k | 52.30 | |
| Cymabay Therapeutics | 0.7 | $13M | 1.6M | 8.06 | |
| Newlink Genetics Corporation | 0.6 | $13M | 1.2M | 10.18 | |
| Model N (MODN) | 0.6 | $13M | 839k | 14.95 | |
| Deciphera Pharmaceuticals (DCPH) | 0.6 | $12M | 723k | 16.54 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 0.5 | $9.5M | 1.9M | 5.05 | |
| Syros Pharmaceuticals | 0.5 | $9.4M | 641k | 14.72 | |
| Cascadian Therapeutics | 0.4 | $8.1M | 2.0M | 4.09 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.4 | $7.8M | 1.6M | 4.85 | |
| Teleflex Incorporated (TFX) | 0.4 | $7.6M | 31k | 241.96 | |
| Cytomx Therapeutics (CTMX) | 0.3 | $6.9M | 382k | 18.17 | |
| Petiq (PETQ) | 0.3 | $6.7M | 247k | 27.08 | |
| Catalent (CTLT) | 0.3 | $5.9M | 148k | 39.92 | |
| Fate Therapeutics (FATE) | 0.3 | $5.6M | 1.4M | 3.96 | |
| Ovid Therapeutics (OVID) | 0.2 | $3.8M | 451k | 8.36 | |
| Neuroderm Ltd F | 0.1 | $3.0M | 77k | 38.90 | |
| Aclaris Therapeutics (ACRS) | 0.1 | $2.6M | 101k | 25.81 | |
| Aurinia Pharmaceuticals (AUPH) | 0.1 | $2.1M | 332k | 6.27 | |
| Hologic (HOLX) | 0.0 | $734k | 20k | 36.70 | |
| UnitedHealth (UNH) | 0.0 | $356k | 1.8k | 195.60 | |
| Neurocrine Biosciences (NBIX) | 0.0 | $407k | 6.6k | 61.30 | |
| Nektar Therapeutics (NKTR) | 0.0 | $350k | 15k | 24.01 | |
| Shire | 0.0 | $208k | 1.4k | 152.94 | |
| LHC | 0.0 | $235k | 3.3k | 71.00 | |
| Castlight Health | 0.0 | $44k | 10k | 4.30 | |
| Adverum Biotechnologies | 0.0 | $81k | 22k | 3.64 |
